Results 121 to 130 of about 9,321 (238)

Author Correction: Functional connectome differences in individuals with hallucinations across the psychosis continuum. [PDF]

Sci Rep, 2021
Schutte MJL, Bohlken MM, Collin G, Abramovic L, Boks MPM, Cahn W, Dauwan M, van Dellen E, van Haren NEM, Hugdahl K, Koops S, Mandl RCW, Sommer IEC.   +12 more
europepmc   +1 more source

Exploring stressor exposure and mental health symptom patterns among forcibly displaced people: A latent profile analysis

Journal of Traumatic Stress, EarlyView.
Abstract The association between trauma exposure and mental health among forcibly displaced people (FDP) is well‐documented. However, prior research has largely employed variable‐centered approaches, which may obscure heterogeneity in individual experiences.
Lisa Dasen, Jennifer Kurath, Béatrice Strock, Karl Juri Weinreich, Julia Spaaij, Matthis Schick, Angela Nickerson, Richard A. Bryant, Naser Morina   +8 more
wiley   +1 more source

The clinical relevance of gray matter atrophy and microstructural brain changes across the psychosis continuum. [PDF]

Schizophr Res, 2021
Hanlon FM, Dodd AB, Ling JM, Shaff NA, Stephenson DD, Bustillo JR, Stromberg SF, Lin DS, Ryman SG, Mayer AR.   +9 more
europepmc   +1 more source

Structurally competent care for families facing the continuous traumatic stress of community violence and systemic racism

Journal of Traumatic Stress, EarlyView.
Abstract In racially and economically segregated communities, structural violence and chronic adversity perpetuate the risk for community violence and related trauma exposure. Despite widespread awareness of community violence, urban youth of color are among those least likely to have access to services that promote trauma recovery. When these youth do
Bradley C. Stolbach, Seeba Anam, Keyona Allen, Emma‐Lorraine Baaba Bart‐Plange, Royce Lee, Aashana Daru, Angel Boulware, Sonya Mathies Dinizulu   +7 more
wiley   +1 more source

High Prevalence and Clinical Impact of Fibromyalgia in Functional Motor Disorder

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Fibromyalgia is characterized by widespread pain, fatigue, sleep and cognitive symptoms. It overlaps clinically with functional motor disorder (FMD), yet its prevalence and impact in FMD remain uncertain. Objective To determine the prevalence of fibromyalgia in FMD using the current criteria and evaluate its effects on motor ...
Tereza Serranová, Lucia Nováková, Martin Jirásek, Barbora Křupková, Evžen Růžička, Michele Tinazzi, Tomáš Sieger   +6 more
wiley   +1 more source

Apathy in Parkinson's Disease: Distinguishing Overlapping Symptoms Via Network Analysis

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Anxiety, fatigue, and excessive daytime sleepiness (EDS) frequently co‐occur in Parkinson's disease (PD) and can influence the clinical determination of apathy. Objective To distinguish patient‐reported apathy from other non‐motor symptoms.
Joseph Seemiller, Abhimanyu Mahajan, Christopher B. Morrow, Joseph F. McGuire, Dawn Bowers, Kelly A. Mills, Gregory M. Pontone   +6 more
wiley   +1 more source

Continuous Intrajejunal Levodopa–Carbidopa Infusion in Parkinson's Disease Associated with 22q11.2 Deletion Syndrome: A Case Series

Movement Disorders Clinical Practice, EarlyView.
Abstract Background 22q11.2 deletion syndrome (22q11DS) is a multisystem genetic disorder associated with a significantly increased risk of early‐onset Parkinson's disease (EOPD). Management is challenging because psychiatric and cognitive comorbidities often limit advanced therapies such as deep brain stimulation (DBS). Cases We report 2 patients with
Valle Victor Andrés, Jardel Amory, Hopes Lucie, Clément Guillemette, Lambert Laetitia, Becker Aurélie, Dexheimer Mylène, Bonnet Céline, Frismand Solène, Renaud Mathilde, Puisieux Salomé   +10 more
wiley   +1 more source

Effect of COMT and UGT1A Variants on Clinical Response to Opicapone in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) is the second most common neurodegenerative disease. Symptomatic treatment is based on dopaminergic replacement. With disease progression, the initial benefit of levodopa becomes inconsistent, and motor complications emerge.
Elena Ojeda‐Lepe, Sergio García‐Díaz, Laura Muñoz‐Delgado, Miguel Martín‐Bórnez, Silvia Jesús, Dolores Buiza‐Rueda, Marta Bonilla‐Toribio, Rafael Díaz‐Belloso, Daniel Macías‐García, Astrid Adarmes‐Gómez, Antonio Luque‐Ambrosiani, Rocío Pineda‐Sánchez, Lorena Clavijo‐Jiménez, Fátima Carrillo‐García, Pilar Gómez‐Garre, Pablo Mir   +15 more
wiley   +1 more source

Social Connectedness across the Psychosis Spectrum: Current Issues and Future Directions for Interventions in Loneliness

Frontiers in Psychiatry, 2014
Michelle H Lim, John F Gleeson
doaj   +1 more source

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Continuous subcutaneous foslevodopa/foscarbidopa (LDp/CDp) provides 24‐h delivery of levodopa‐carbidopa prodrugs for advanced Parkinson's disease. Real‐world 1‐year European data remain limited. Objectives To characterize 1‐year changes in motor, non‐motor, autonomic, quality‐of‐life and sleep outcomes, and in concomitant therapy ...
Mario Hero, Nadja Grozdanić, Romana Brnić Andrić, Eliša Papić, Olivio Perković, Vladimira Vuletić   +5 more
wiley   +1 more source